Pdb78 - Economic Evaluation of Dapagliflozin as Add-On to Metformin for T2dm Treatment in the Israeli Healthcare Setting

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.783
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Dapagliflozin: Cost-Effectiveness as an Add-On Therapy to Metformin in the Treatment of Type 2 Diabetes (T2DM) in Argentina and Chile

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Cost-Effectiveness of Dapagliflozin Versus DPP-4 Inhibitors as an Add-On to Metformin in the Treatment of Type 2 Diabetes Mellitus From a UK Healthcare System Perspective

BMC Health Services Research
Health Policy
2015English

Cost-Effectiveness of Dapagliflozin as Add-On to Insulin for the Treatment of Type 2 Diabetes in the Netherlands

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Cost-Effectiveness Analysis of Linagliptin Versus Sulfonylurea as Add-On Treatment to Metformin for the Treatment of Diabetes Mellitus Type 2 Patients in Indonesia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-On to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2015English

Economic Evaluation of Dapagliflozin Versus Metformin in Chinese Patients Whose Diabetes Is Inadequately Controlled With Diet and Exercise

Cost Effectiveness and Resource Allocation
Health Policy
2020English

Retrospective Evaluation of Deep Transcranial Magnetic Stimulation as Add-On Treatment for Parkinson’s Disease

Frontiers in Neurology
Neurology
2015English

Dapagliflozin (Forxiga®) Versus Glipizide as Add-On Therapies in Type 2 Diabetes Mellitus (T2dm); An Update of the Cost-Effectiveness Based on Long-Term Clinical Evidence From Uk NHS Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Evaluation of the Efficacy and Safety of Lixisenatide Add-On Treatment to Basal Insulin Therapy Among T2DM Patients With Different Body Mass Indices From GetGoal Trials

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy